ML-007C-MA

· MapLight Therapeutics

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ML-007C-MA, covering 2026-03-09 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia [Phase 2]